Literature DB >> 8825346

Cyclic AMP-elevating agents prolong or inhibit eosinophil survival depending on prior exposure to GM-CSF.

M P Hallsworth1, M A Giembycz, P J Barnes, T H Lee.   

Abstract

1. Purified human eosinophils survived for up to 7 days when cultured in vitro in the presence of 1 ng ml-1 granulocyte-macrophage colony stimulating factor (GM-CSF) with a viability of 73%. In the absence of GM-CSF, eosinophil viability decreased after one day in culture, and only 4% of cells were viable by day 4. 2. Culture of eosinophils with cholera toxin produced a concentration-dependent decrease in GM-CSF-induced survival at 7 days (IC50 = 7 ng ml-1) which was associated with a 6 fold increase in the intracellular cyclic AMP concentration. This inhibition of cell survival could be prevented by the addition of the protein kinase A inhibitor, H89 (10(-6)M). 3. When eosinophils were cultured with dibutyryl cyclic AMP, there was a concentration-dependent inhibition of GM-CSF-induced survival at 7 days with an IC50 of 200 microM. The related cyclic nucleotide analogue, dibutyryl cyclic GMP did not inhibit GM-CSF-induced eosinophil survival over the same concentration range. 4. Culture of eosinophils with forskolin, or with the phosphodiesterase inhibitors, rolipram and SK&F94120, had no effect on GM-CSF-induced eosinophil survival at any concentration examined. 5. After 7 days' culture in the absence of GM-CSF, fractionation of eosinophil DNA on agarose gels demonstrated a 'ladder' pattern characteristic of apoptosis. GM-CSF prevented DNA fragmentation and this protection could be overcome by both cholera toxin and dibutyryl cyclic AMP. 6. GM-CSF did not affect intracellular cyclic AMP concentrations in unstimulated eosinophils or in cells stimulated by cholera toxin. Thus, GM-CSF does not apparently increase eosinophil survival by affecting cyclic AMP levels. 7. In the absence of GM-CSF both cholera toxin and dibutyryl cyclic AMP decreased the rate of eosinophil death, when compared to cells cultured with medium alone. The t1/2 values for cell death were 1.63 +/- 0.3, 2.46 +/- 0.3 and 4.62 +/- 1.0 days for cells cultured in the presence of medium, cholera toxin and dibutyryl cyclic AMP respectively. 8. In conclusion, cyclic AMP exerts opposing effects on eosinophil survival depending on prior exposure of the cells to GM-CSF.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8825346      PMCID: PMC1909360          DOI: 10.1111/j.1476-5381.1996.tb15157.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  50 in total

1.  Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5.

Authors:  M Stern; L Meagher; J Savill; C Haslett
Journal:  J Immunol       Date:  1992-06-01       Impact factor: 5.422

2.  An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils.

Authors:  T T Hansel; I J De Vries; T Iff; S Rihs; M Wandzilak; S Betz; K Blaser; C Walker
Journal:  J Immunol Methods       Date:  1991-12-15       Impact factor: 2.303

3.  Peripheral blood eosinophil counts and bronchial responsiveness.

Authors:  K J Taylor; A R Luksza
Journal:  Thorax       Date:  1987-06       Impact factor: 9.139

4.  Regulation of Ig-induced eosinophil degranulation by adenosine 3',5'-cyclic monophosphate.

Authors:  H Kita; R I Abu-Ghazaleh; G J Gleich; R T Abraham
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

5.  Cytokine priming of the respiratory burst in human eosinophils is Ca2+ independent and accompanied by induction of tyrosine kinase activity.

Authors:  T van der Bruggen; P T Kok; J A Raaijmakers; A J Verhoeven; R G Kessels; J W Lammers; L Koenderman
Journal:  J Leukoc Biol       Date:  1993-04       Impact factor: 4.962

6.  Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity.

Authors:  T J Torphy; H L Zhou; L B Cieslinski
Journal:  J Pharmacol Exp Ther       Date:  1992-12       Impact factor: 4.030

7.  Identification of the major activity derived from cultured human peripheral blood mononuclear cells, which enhances eosinophil viability, as granulocyte macrophage colony-stimulating factor (GM-CSF).

Authors:  L A Burke; M P Hallsworth; T M Litchfield; R Davidson; T H Lee
Journal:  J Allergy Clin Immunol       Date:  1991-08       Impact factor: 10.793

8.  Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhibitors.

Authors:  G Dent; M A Giembycz; K F Rabe; P J Barnes
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

9.  Characterization of guinea-pig eosinophil phosphodiesterase activity. Assessment of its involvement in regulating superoxide generation.

Authors:  J E Souness; C M Carter; B K Diocee; G A Hassall; L J Wood; N C Turner
Journal:  Biochem Pharmacol       Date:  1991-07-25       Impact factor: 5.858

10.  Cytokine mRNA profile and cell activation in bronchoalveolar lavage fluid from nonatopic patients with symptomatic asthma.

Authors:  M Marini; E Avoni; J Hollemborg; S Mattoli
Journal:  Chest       Date:  1992-09       Impact factor: 9.410

View more
  5 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  Murine myeloid progenitor responses to GM-CSF and eosinophil precursor responses to IL-5 represent distinct targets for downmodulation by prostaglandin E(2).

Authors:  M I Gaspar Elsas; D Joseph; L Lintomen; E S Maximiano; M Bodstein; P Xavier Elsas; B B Vargaftig
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

3.  Eosinophil viability is increased by acidic pH in a cAMP- and GPR65-dependent manner.

Authors:  Leah C Kottyan; Ann R Collier; Khanh H Cao; Kathryn A Niese; Megan Hedgebeth; Caius G Radu; Owen N Witte; Gurjit K Khurana Hershey; Marc E Rothenberg; Nives Zimmermann
Journal:  Blood       Date:  2009-07-29       Impact factor: 22.113

4.  Inhibition of neutrophil apoptosis by ATP is mediated by the P2Y11 receptor.

Authors:  Kathryn R Vaughan; Leanne Stokes; Lynne R Prince; Helen M Marriott; Sabine Meis; Matthias U Kassack; Colin D Bingle; Ian Sabroe; Annmarie Surprenant; Moira K B Whyte
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

5.  Phosphodiesterase 4 inhibitors and db-cAMP inhibit TNF-alpha release from human mononuclear cells. Effects of cAMP and cGMP-dependent protein kinase inhibitors.

Authors:  A Hichami; E Boichot; N Germain; E Berdyshev; O Coqueret; V Lagente
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.